Brief: Cumberland Pharmaceuticals Q3 Revenue Rose 22% To $10.4 Million
12/11/2019 21:22
Nov 12 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS 22% REVENUE GROWTH IN
THE
THIRD QUARTER
* Q3 ADJUSTED EARNINGS PER SHARE $0.01
* Q3 LOSS PER SHARE $0.13
* Q3 REVENUE ROSE 22 PERCENT TO $10.4 MILLION
Source text for Eikon: ID:nPn9hhGP7a
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM